Sanofi partnering with leading academics to study amcenestrant for breast cancer treatment Ruchika Sharma7 Jun 2021 10:30 AM ISTAmcenestrant is an oral SERD that antagonizes and degrades the estrogen receptor (ER), resulting in inhibition of the ER signaling pathway.
Sanofi-Merck six-in-one pediatric combination vaccine Vaxelis available in US Ruchika Sharma3 Jun 2021 11:00 AM ISTBridgewater: Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B...
Patent Infringement: Panacea Biotec sues Sanofi in Delhi HC over pediatric vaccine medical dialogues team19 May 2021 2:40 PM ISTPunjab: In a major setback to Sanofi Healthcare India, Panacea Biotec has moved the Delhi High Court against the firm seeking to restrain it from...
GSK, Sanofi COVID vaccine Phase 2 trial shows strong immune responses across all adult age groups Ruchika Sharma18 May 2021 10:00 AM ISTParis: The Sanofi and GSK adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates of neutralizing antibody responses, in line with...
Sanofi enters three-year collaboration with Stanford Medicine to advance immunology research Ruchika Sharma9 May 2021 9:00 AM ISTParis: Sanofi has recently announced that the company has entered into a three-year research collaboration with Stanford University School of...
Sanofi to infuse Euro 400 million in new vaccine production site Ruchika Sharma15 April 2021 12:33 PM ISTParis: Sanofi has recently announced a EURO 400 million investment over five years to create a unique vaccine production center in Singapore, pushing...
Sanofi gets USFDA nod for Sarclisa, Carfilzomib, Dexamethasone combo to treat multiple myeloma Ruchika Sharma3 April 2021 11:00 AM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (USFDA) has approved Sarclisa (isatuximab) in combination with carfilzomib and...
Sanofi, Regeneron phase 3 trial of Libtayo in advanced cervical cancer stopped early for positive result Ruchika Sharma17 March 2021 10:00 AM ISTParis and Tarrytown: Positive results demonstrating an overall survival (OS) benefit from the Phase 3 trial investigating Sanofi and Regeneron's PD-1...
Include more Govt sites: CDSCO panel to Sanofi on clinical trial of pulmonary disease drug Medical Dialogues Team16 March 2021 9:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Sanofi Pasteur, Translate Bio begin Phase 1/2 clinical trial of mRNA COVID-19 vaccine Ruchika Sharma15 March 2021 1:35 PM ISTParis and Lexington: Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA)...
Sanofi, GSK begin Phase 2 study of protein-based COVID-19 vaccine Ruchika Sharma23 Feb 2021 12:03 PM ISTParis and London: Sanofi and GSK have recently announced the initiation of a new Phase 2 study with 720 volunteers aged 18 and over to select the most...
Sanofi, Bristol Myers directed to pay USD 834 million over Plavix warning label Ruchika Sharma18 Feb 2021 12:44 PM ISTOchiai, who presided over a four week, non jury trial conducted entirely over Zoom due to the COVID-19 pandemic, ordered Bristol Myers and Sanofi to...
